Herbas VPB

Print
EN | LT
LT - Autizmo spektro susirgimų gydymas, naudojant glicil-L-2-metilprolil-L-glutamo rūgštį
EN - TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/06 (2006.01)
A61K 45/06 (2006.01)
A61K 31/41 (2006.01)
A61K 31/401 (2006.01)
A61K 9/00 (2006.01)
A61K 9/127 (2006.01)
A01N 43/64 (2006.01)
A61P 25/00 (2006.01)
European patent
(11) Number of the document 2667715
(13) Kind of document T
(96) European patent application number 12739509.3
Date of filing the European patent application 2012-01-27
(97) Date of publication of the European application 2013-12-04
(45) Date of publication and mention of the grant of the patent 2017-07-19
(46) Date of publication of the claims translation 2017-11-10
PCT application
(86) Number PCT/US2012/000047
Date 2012-01-27
PCT application publication
(87) Number WO 2012/102832
Date 2012-08-02
Priority applications
(30) Number Date Country code
201161462141 P 2011-01-27 US
201161492248 P 2011-06-01 US
Inventors
(72)
GLASS, Larry, US
BICKERDIKE, Michael John, NZ
SNAPE, Michael Frederick, GB
Grantee
(73) Neuren Pharmaceuticals Limited, Lowndes Jordan Level 15 PWC Tower 188 Quay Street, Auckland 1141, NZ
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Autizmo spektro susirgimų gydymas, naudojant glicil-L-2-metilprolil-L-glutamo rūgštį
  TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID
Last renewal fee
Payment date Validity (years) Amount
2024-12-31 14 289.00 EUR
Next renewal fee
2026-01-27
Last update date 2025-01-03